Researchers at Tel Aviv University (TAU) discovered a new factor in the pathology of Parkinson's disease, which in the future ...
Researchers at Tel Aviv University (TAU) discovered a new factor in the pathology of Parkinson's disease, which in the future ...
The researchers note that, "despite the similarities, patients with these diseases have a different prognosis and do not ...
AC Immune (ACIU) stock shot up 20% Thursday after the company reported positive data from a Phase 2 study of its drug ...
Analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's treatment ...
According to recent research, astrocyte cell transplantation could revolutionize treatments for neurological disorders such ...
AC Immune SA (ACIU) has released an update. AC Immune SA announced promising interim results from its Phase 2 trial of the ACI-7104.056 ...
News Medical on MSN2d
New biomarker could help predict Parkinson’s disease progressionA team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.
This year has seen several biopharma companies drop Alzheimer’s and Parkinson’s disease programs, but experts say plenty are ...
The researchers note that, "despite the similarities, patients with these diseases have a different prognosis and do not ...
Israeli scientists have identified a promising new factor in the pathology of Parkinson’s disease that could pave the way for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback